Permanent position available for a Fragment-based Lead Generation (FBLG) Specialist. Based at Alderley Park, UK
If you're an expert in crystallography and FBLG, here's the chance to make a key impact with a major pharmaceutical company. About the role Playing an influential role in drug discovery, you'll demonstrate the power of fragment-based approaches in lead generation projects. It's a fantastic opportunity to enhance our capabilities in this area and to provide mentorship for less experienced scientists. As well as leading FBLG projects, you'll also contribute expertise in crystallography and complementary biophysical techniques. About you We're looking for a PhD-qualified scientist with expertise in X-ray crystallography and crystallisation applied to the study of protein:ligand complexes. In addition to academic post-doctoral experience, you should have a strong track record in fragment-based drug discovery. This will include experience of collaborating with medicinal and computational chemists to drive FBLG projects. About us One of the world's leading pharmaceutical companies, AstraZeneca is committed to developing innovative medicines that make a real difference to people's lives. We believe FBLG approaches will be increasingly important in the quest to find new medicines. In this role, you'll drive our progress in this area. To apply, please visit www.careers.astrazeneca.co.uk and search for job reference DECS5157. Closing date: 27th September 2009. -------------------------------------------------------------------------- AstraZeneca UK Limited is a company incorporated in England and Wales with registered number: 03674842 and a registered office at 15 Stanhope Gate, London W1K 1LN. Confidentiality Notice: This message is private and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorised use or disclosure of the contents of this message is not permitted and may be unlawful. Disclaimer: Email messages may be subject to delays, interception, non-delivery and unauthorised alterations. Therefore, information expressed in this message is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by an authorised representative independent of this message. No contractual relationship is created by this message by any person unless specifically indicated by agreement in writing other than email. Monitoring: AstraZeneca UK Limited may monitor email traffic data and content for the purposes of the prevention and detection of crime, ensuring the security of our computer systems and checking Compliance with our Code of Conduct and Policies.
